GB201514902D0 - Formulations for transmucosal delivery - Google Patents

Formulations for transmucosal delivery

Info

Publication number
GB201514902D0
GB201514902D0 GBGB1514902.4A GB201514902A GB201514902D0 GB 201514902 D0 GB201514902 D0 GB 201514902D0 GB 201514902 A GB201514902 A GB 201514902A GB 201514902 D0 GB201514902 D0 GB 201514902D0
Authority
GB
United Kingdom
Prior art keywords
formulations
transmucosal delivery
transmucosal
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1514902.4A
Other versions
GB2534623A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corbitt Terence S
Original Assignee
Corbitt Terence S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corbitt Terence S filed Critical Corbitt Terence S
Publication of GB201514902D0 publication Critical patent/GB201514902D0/en
Publication of GB2534623A publication Critical patent/GB2534623A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GB1514902.4A 2014-08-21 2015-08-21 Formulations for transmucosal delivery Withdrawn GB2534623A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1414918.1A GB201414918D0 (en) 2014-08-21 2014-08-21 Formulations for transmucosal delivery

Publications (2)

Publication Number Publication Date
GB201514902D0 true GB201514902D0 (en) 2015-10-07
GB2534623A GB2534623A (en) 2016-08-03

Family

ID=51726924

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB1414918.1A Ceased GB201414918D0 (en) 2014-08-21 2014-08-21 Formulations for transmucosal delivery
GB1514902.4A Withdrawn GB2534623A (en) 2014-08-21 2015-08-21 Formulations for transmucosal delivery

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB1414918.1A Ceased GB201414918D0 (en) 2014-08-21 2014-08-21 Formulations for transmucosal delivery

Country Status (1)

Country Link
GB (2) GB201414918D0 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020225832A1 (en) * 2019-05-07 2020-11-12 Sveinbjorn Gizurarson Preventing incompatibility among malarial drugs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100463669C (en) * 2006-08-31 2009-02-25 广州市医药工业研究所 Self-emulsifying agent of compound artemether
GB0720967D0 (en) * 2007-10-25 2007-12-05 Protophama Ltd Anti-material pharmaceutical composition
WO2011141935A2 (en) * 2010-05-12 2011-11-17 Gujarat Liqui Pharmacaps Pvt. Ltd Soft capsular preparation of artemether and lumefantrine and process to manufacture same
CN103251584A (en) * 2013-05-09 2013-08-21 西安力邦制药有限公司 Preparation of artemether/benflumetol compound fat emulsion for injection and application of artemether/benflumetol compound fat emulsion in malaria treatment

Also Published As

Publication number Publication date
GB201414918D0 (en) 2014-10-08
GB2534623A (en) 2016-08-03

Similar Documents

Publication Publication Date Title
HK1245071A1 (en) Compositions for ileo-jejunal drug delivery
GB2545368B (en) Diversion-resistant opioid formulations
IL246978A0 (en) Novel pharmaceutical formulations
HK1225655A1 (en) Pharmaceutical compositions comprising azd9291
GB2521845B (en) Content delivery
GB201407614D0 (en) Content delivery system
GB201419261D0 (en) Formulations
GB201419091D0 (en) Formulations
ZA201608085B (en) Grout delivery
ZA201605787B (en) Formulations for small intestinal delivery
IL247106B (en) Substance delivery system
GB2524838B (en) Content delivery architecture
SG11201704137RA (en) Formulation for effective tocotrienol delivery
PT3200772T (en) Pharmaceutical compositions comprising alpelisib
GB201417589D0 (en) Pharmaceutical Formulations
GB201514902D0 (en) Formulations for transmucosal delivery
GB201514906D0 (en) Formulations for transmucosal delivery
HU4501U (en) Delivery slip
GB201415325D0 (en) Content delivery system
GB201405197D0 (en) Delivery suite- whelping system

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)